Raia Drogasil S.A. (RADLY)
USD 3.57
(-3.39%)
USD 3.57
(-3.39%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.05 Billion BRL | 5.91% |
| 2022 | 996.11 Million BRL | 32.47% |
| 2021 | 751.93 Million BRL | 55.22% |
| 2020 | 484.44 Million BRL | -37.27% |
| 2019 | 772.24 Million BRL | 53.7% |
| 2018 | 502.44 Million BRL | -1.71% |
| 2017 | 511.16 Million BRL | 14.18% |
| 2016 | 447.68 Million BRL | 31.59% |
| 2015 | 340.2 Million BRL | 53.67% |
| 2014 | 221.38 Million BRL | 119.23% |
| 2013 | 100.98 Million BRL | -3.69% |
| 2012 | 104.85 Million BRL | 52.64% |
| 2011 | 68.69 Million BRL | -22.83% |
| 2010 | 89.01 Million BRL | 19.34% |
| 2009 | 74.59 Million BRL | 45.76% |
| 2008 | 51.17 Million BRL | 136.63% |
| 2007 | 21.62 Million BRL | 4.0% |
| 2006 | 20.79 Million BRL | 113.83% |
| 2005 | 9.72 Million BRL | 22.31% |
| 2004 | 7.95 Million BRL | 14.25% |
| 2003 | 6.95 Million BRL | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 187.81 Million BRL | -28.0% |
| 2024 Q2 | 326.63 Million BRL | 73.91% |
| 2023 Q4 | 260.84 Million BRL | -1.08% |
| 2023 Q3 | 263.68 Million BRL | -22.03% |
| 2023 Q1 | 192.26 Million BRL | -32.59% |
| 2023 Q2 | 338.18 Million BRL | 75.9% |
| 2023 FY | 1.05 Billion BRL | 5.91% |
| 2022 Q4 | 285.22 Million BRL | 32.41% |
| 2022 Q1 | 140.64 Million BRL | -17.44% |
| 2022 Q2 | 354.83 Million BRL | 152.3% |
| 2022 FY | 996.11 Million BRL | 32.47% |
| 2022 Q3 | 215.4 Million BRL | -39.29% |
| 2021 Q3 | 154.53 Million BRL | -38.86% |
| 2021 FY | 751.93 Million BRL | 55.22% |
| 2021 Q4 | 170.35 Million BRL | 10.24% |
| 2021 Q1 | 174.29 Million BRL | 7.78% |
| 2021 Q2 | 252.75 Million BRL | 45.01% |
| 2020 Q1 | 123.32 Million BRL | 43.47% |
| 2020 Q2 | 44.67 Million BRL | -63.77% |
| 2020 Q4 | 161.72 Million BRL | 4.52% |
| 2020 FY | 484.44 Million BRL | -37.27% |
| 2020 Q3 | 154.72 Million BRL | 246.33% |
| 2019 Q3 | 459.34 Million BRL | 231.79% |
| 2019 FY | 772.24 Million BRL | 53.7% |
| 2019 Q1 | 88.5 Million BRL | -24.41% |
| 2019 Q2 | 138.44 Million BRL | 56.43% |
| 2019 Q4 | 85.95 Million BRL | -81.29% |
| 2018 Q1 | 120.95 Million BRL | -9.58% |
| 2018 FY | 502.44 Million BRL | -1.71% |
| 2018 Q4 | 117.08 Million BRL | -8.49% |
| 2018 Q3 | 127.94 Million BRL | -6.24% |
| 2018 Q2 | 136.45 Million BRL | 12.82% |
| 2017 Q1 | 103.85 Million BRL | 19.98% |
| 2017 Q4 | 133.76 Million BRL | -1.69% |
| 2017 FY | 511.16 Million BRL | 14.18% |
| 2017 Q3 | 136.06 Million BRL | -1.03% |
| 2017 Q2 | 137.48 Million BRL | 32.38% |
| 2016 Q4 | 86.55 Million BRL | -25.28% |
| 2016 FY | 447.68 Million BRL | 31.59% |
| 2016 Q1 | 90 Million BRL | 16.36% |
| 2016 Q3 | 115.84 Million BRL | -25.4% |
| 2016 Q2 | 155.28 Million BRL | 72.53% |
| 2015 FY | 340.2 Million BRL | 53.67% |
| 2015 Q2 | 108.22 Million BRL | 53.89% |
| 2015 Q4 | 77.34 Million BRL | -8.25% |
| 2015 Q3 | 84.3 Million BRL | -22.1% |
| 2015 Q1 | 70.32 Million BRL | 13.15% |
| 2014 FY | 221.38 Million BRL | 119.23% |
| 2014 Q1 | 29.13 Million BRL | 4.72% |
| 2014 Q2 | 62.12 Million BRL | 113.24% |
| 2014 Q3 | 67.97 Million BRL | 9.43% |
| 2014 Q4 | 62.15 Million BRL | -8.57% |
| 2013 Q4 | 27.81 Million BRL | 49.41% |
| 2013 FY | 100.98 Million BRL | -3.69% |
| 2013 Q3 | 18.61 Million BRL | -53.77% |
| 2013 Q2 | 40.27 Million BRL | 182.02% |
| 2013 Q1 | 14.27 Million BRL | 914.85% |
| 2012 Q1 | 19.38 Million BRL | 168.1% |
| 2012 FY | 104.85 Million BRL | 52.64% |
| 2012 Q4 | 1.4 Million BRL | -95.95% |
| 2012 Q3 | 34.72 Million BRL | -29.6% |
| 2012 Q2 | 49.33 Million BRL | 154.48% |
| 2011 FY | 68.69 Million BRL | -22.83% |
| 2011 Q3 | 22.22 Million BRL | -19.66% |
| 2011 Q2 | 27.65 Million BRL | 137.83% |
| 2011 Q1 | 11.62 Million BRL | -47.33% |
| 2011 Q4 | 7.23 Million BRL | -67.46% |
| 2010 Q1 | 16.02 Million BRL | -14.48% |
| 2010 FY | 89.01 Million BRL | 19.34% |
| 2010 Q4 | 22.07 Million BRL | 0.92% |
| 2010 Q3 | 21.87 Million BRL | -24.65% |
| 2010 Q2 | 29.03 Million BRL | 81.19% |
| 2009 FY | 74.59 Million BRL | 45.76% |
| 2009 Q4 | 18.73 Million BRL | -5.8% |
| 2009 Q3 | 19.89 Million BRL | -10.02% |
| 2009 Q2 | 22.1 Million BRL | 59.53% |
| 2009 Q1 | 13.85 Million BRL | 0.0% |
| 2008 FY | 51.17 Million BRL | 136.63% |
| 2007 FY | 21.62 Million BRL | 4.0% |
| 2006 FY | 20.79 Million BRL | 113.83% |
| 2005 FY | 9.72 Million BRL | 22.31% |
| 2004 FY | 7.95 Million BRL | 14.25% |
| 2003 FY | 6.95 Million BRL | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | 28488399.246% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 211372.212% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | -1424.825% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 140733.627% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -49.02 Thousand USD | 2152139.9% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 59582.685% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | -1922.804% |
| MedGen, Inc. | -15.54 USD | 6788758143.758% |
| Omni Health, Inc. | 1.26 Million USD | -83254.969% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 352812.276% |
| Pineapple, Inc. | -1.47 Million USD | 71496.0% |
| ScripsAmerica, Inc. | -4.73 Million USD | 22398.938% |